Using genomics to better define high-risk MGUS/SMM patients.

Dutta, Ankit K; Hewett, Duncan R; Fink, J Lynn; Zannettino, Andrew C W

Dutta, Ankit K; Hewett, Duncan R; Fink, J Lynn; Zannettino, Andrew C W.

Affiliation

Dutta AK; Andrew C.W. Zannettino: Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Hewett DR; Andrew C.W. Zannettino: Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Fink JL; Andrew C.W. Zannettino: Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Zannettino ACW; Andrew C.W. Zannettino: Myeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Cancer Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.

Oncotarget ; 9(93): 36549-36550, 2018 Nov 27.

Article in En | MEDLINE | ID: mdl-30564295

Key words

clonal evolution; genomics; intraclonal heterogeneity; multiple myeloma; smoldering multiple myeloma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google